Share This Article:

Holistic Psychopharmacology and Promiscuous Plants and Principles of Ayurveda

Abstract Full-Text HTML XML Download Download as PDF (Size:96KB) PP. 1015-1021
DOI: 10.4236/ajps.2012.327120    4,817 Downloads   7,927 Views   Citations

ABSTRACT

Consistent neglect of complex psychobiological processes involved in human health and diseases often leads to phar-macological discrepancies between preclinical and therapeutic observations. Numerous other pharmacological paradoxes arise from common practices of using dosing schedules in preclinical studies not identical to those in clinical studies. An Ayurveda centered holistic psychopharmacological strategy evolving from our efforts to identify plants potentially useful for preventing and combating illnesses and diseases could be a more rapid, rational, economically feasible, and realistic one for resolving such discrepancies and paradoxes. In this article, some observations made recently to experimentally very this conviction with the use of some well known medicinal plants are summarized and discussed in short. In addition, usefulness of the strategy for identifying edibles potentially useful for health care purposes, or for more objectively understanding “Ayurvedic biology” is pointed out.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

S. Chatterjee and V. Kumar, "Holistic Psychopharmacology and Promiscuous Plants and Principles of Ayurveda," American Journal of Plant Sciences, Vol. 3 No. 7A, 2012, pp. 1015-1021. doi: 10.4236/ajps.2012.327120.

References

[1] K. S. Nagral, “Ayurved for modern medical practitioners,” Chaukhamba Publishing House, New Delhi, India, 2008.
[2] R. A. Bond, “Is paradoxical pharmacology a strategy worth pursuing?” Trends in Pharmacological Sciences, Vol. 22, No. 6, 2001, pp. 273-276.
[3] C. Page, “Paradoxical pharmacology: turning our pharmacological models upside down,” Trends in Pharmacological Sciences, Vol. 32, No. 4, 2011, pp. 197-200.
[4] V. Kumar and S. S. Chatterjee, “Ethnopharmacology and rational evaluation of herbal remedies,” In: M. Eddouks, Ed., Handbook of Ethnopharmacology, Research Signpost, Kerala, India, 2008, pp. 25-50.
[5] S. B. Kayne, “Introduction to traditional medicine,” In: S.B. Kayne, Ed., Complementary and Alternative Medicine, 2nd Edition, Pharmaceutical Press, London, 2009, pp. 1-24.
[6] S. Ventegodt, I. Kandel and J. Merrick, “A short history of clinical holistic medicine,” The Scientific World Journal: TSW Holistic Health & Medicine, Vol. 7, 2007, pp. 1622-1630. doi:10.1100/tsw.2007.238.
[7] C. R. Chong and D.J. Sullivan, “New uses for old drugs,” Nature, Vol. 448, No. 7154, 2007, pp. 645-646.
[8] J. K. Aronson, “Editors′view: Old drugs-new uses,” British Journal of Clinical Pharmacology, Vol. 64, No. 5, 2007, pp. 563-565.
[9] K. Hamilton-West, “Psychobiological processes in Health and Illness,” Sage Publications, UK, 2011.
[10] G. M. Husain, S. S. Chatterjee, P. N. Singh and V. Kumar, “Hypolipidemic and antiobesity like activity of standardised extract of Hypericum perforatum L. in rats,” ISRN Pharmacology, Article ID 505247, 2011. doi:10.5402/2011/505247.
[11] G. M. Husain, S. S. Chatterjee, P. N. Singh and V. Kumar, “Beneficial effect of Hypericum perforatum on depression and anxiety in a type 2 diabetic rat model,” Acta Poloniae Pharmaceutica, Vol. 68, No. 6, 2011, pp. 913-918.
[12] N. Kumar, G.M. Husain, P. N. Singh and V. Kumar, “Antiaggressive activity of hyperforin: a preclinical study,” Drug Discoveries & Therapeutics, Vol. 3, No. 4, 2009, pp. 162-167.
[13] G. M. Husain, P. N. Singh and V. Kumar, “Beneficial effects of a standardized Hypericum perforatum extract in rats with experimentally induced hyperglycemia,” Drug Discoveries & Therapeutics, Vol. 3, No. 5, 2009, pp. 215-220.
[14] S. Ineedi and V. Kumar, “Anti-hyperlipidemic activity of hyperforin: an in vivo study in rats,” Pharmacologyonline, Vol. 2, 2009, pp. 133-139.
[15] G. M. Husain, S. S. Chatterjee, P. N. Singh and V. Kumar, “Antiaggressive activity of standaridised extract of Indian Hypericum perforatum L,” Pharmacologyonline, Vol. 1, 2009, pp. 432-444.
[16] G. M. Husain, P. N. Singh and V. Kumar, “Anti-diabetic activity of Indian Hypericum perforatum L. on alloxan-induced diabetic rats,” Pharmacologyonline, Vol. 3, 2008, pp. 889-894.
[17] Y. M. Farag and M. R. Gaballa, “Diabesity: an overview of a rising epidemic,” Nephrology, Dialysis, Transplantation: Official Publication of The European Dialysis and Transplant Association - European Renal Association, Vol. 26, No. 1, 2011, pp. 28-35.
[18] D. C. Lau, J. D. Douketis, K. M. Morrison, I. M. Hramiak, A. M. Sharma, E. Ur and Obesity Canada Clinical Practice Guidelines Expert Panel, “2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary],” Canadian Medical Association Journal, Vol. 176, No. 8, 2007, pp. S1-S13.
[19] National Institutes of Health, “Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report,” Obesity research, Vol. 6, No. 2 (Suppl.), 1998, pp. 51S-209S.
[20] J. Ho, A. K. C. Leung and D. Rabi, “Hypoglycemic agents in management of type 2 diabetes mellitus,” Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, No. 1, 2011, pp. 66-73.
[21] A. H. C. Wong, S. S. N. Barg and A. K. C Leung, “Pharmacotherapy of obesity,” Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 4, No. 1, 2010, pp. 47-58.
[22] V. Kumar, G. M. Husain and S. S. Chatterjee, “Search for Plants against Diabesity: a comparative preclinical study,” LAP-Lambert Academic Publishing AG & Co. KG, Saarbrücken, Germany, 2011.
[23] G. M. Husain, P. N. Singh, R. K. Singh and V. Kumar, “Anti-diabetic activity of standardised extract of Quassia amara in nicotina-mide-streptozotocin-induced diabetic rats,” Phytotherapy Research, Vol. 25, No. 12, 2011, pp. 1806-1812.
[24] G. M. Hu-sain, A. K. Thakur, P. N. Singh and V. Kumar, “Effect of Picrorhiza kurroa & Quassia amara on high fat diet induced obesity in rats,” Proceedings of the Update Ayurveda 2010, jointly organized by Ayurveda Research Centre, Seth GS Medical College & KEM Hospital and Sharadini Dahanu-kar-Advanced Centre for Ayurveda Research, Training & Services, T.N. Medical College & BYL Nair Ch. Hospital Mumbai, India, 25-27 November, 2010.
[25] G. M. Husain, A. K. Thakur, P. N. Singh and V. Kumar, “Lack of antidepressant and anxiolytic activity of Picrorhiza kurroa and Quassia amara in streptozotocin induced diabetic rats,” Proceedings of the International Symposium on Brain Aging and Dementia: Basic and Translational Aspects, organized by Banaras Hindu University, Varanasi, India, 29-30 November, 2010.
[26] G. M. Husain, P. N. Singh and V. Kumar, “Improvement of cognitive functions by Hypericum perforatum in streptozotocin induced diabetic rats,” Proceedings of the International Symposium on Brain Aging and Dementia: Basic and Translational Aspects, organized by Banaras Hindu University, Varanasi, India, 29-30 November, 2010.
[27] G. M. Husain, P. N. Singh, R. K. Singh and V. Kumar, “Effect of Hypericum perforatum, Picrohiza kurroa & Quassia amara on plasma insulin level in nicotina-mide-streptozocin-induced diabetic rats,” Proceedings of the 43rd Annual Conference of Indian Pharmacological Society & International Conference on Pharmacology and Translational Research, organized by National Executive Committee 2010-IPS in Association with Food and Toxicology Research Centre, National Institute of Nutrition, Hyderabad, India, 13-16 Dec
[28] G. M. Husain, P. N. Singh and V. Kumar, “Antidiabetic activity of standardized extract of Picrorhiza kurroa in rat model of NIDDM,” Drug Discoveries & Thera-peutics, Vol. 3, No. 3, 2009, pp. 88-92.
[29] G. K. Singh and V. Kumar, “Acute and subchronic toxicity study of standardized extract of Fumaria indica in rodents,” Journal of Ethnopharmacology, Vol. 134, No. 3, 2011, pp. 992-995.
[30] G. K. Singh, S. K. Chauhan, G. Rai and V. Kumar, “Fumaria indica is safe during chronic toxicity and cytotoxicity: a preclinical study,” Journal of Pharmacology & Pharmacotherapeutics, Vol. 2, No. 3, 2011, pp. 191-192.
[31] G. K. Singh and V. Kumar, “General neuropharmacological screening and lack of antidepressant activity of standardized extract of Fumaria indica: a preclinical study,” Electronic Journal of Pharmacology and Therapy, Vol. 3, 2010, pp.19-28.
[32] G. K. Singh, R. Nageswar and V. Kumar, “Analgesic and anti-inflammatory activity of standardized extract of Fumaria indica,” Proceedings of the 62nd Indian Pharmaceutical Congress, organized by Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, India, 17-19 December, 2010.
[33] G. K. Singh, A. Kumar and V. Kumar, “Fumaria indica reverses sodium nitrite induced amnesia in rodents,” Proceedings of the Update Ayurveda 2010, jointly organized by Ayurveda Research Centre, Seth GS Medical College & KEM Hospital and Sharadini Dahanukar-Advanced Centre for Ayurveda Research, Training & Services, T.N. Medical College & BYL Nair Ch. Hospital Mumbai, India, 25-27 November, 2010.
[34] G. K. Singh and V. Kumar, “Memory enhancing and anti-amnestic activity of standardized extract of Fumaria indica: an in vivo study,” Proceedings of the International Symposium on Brain Aging and Dementia: Basic and Translational Aspects, organized by Banaras Hindu University, Varanasi, India, 29-30 November, 2010.
[35] G. K. Singh, A. Kumar and V. Kumar, “Fumaria indica enhances memory and reverses electroconvulsive shock induced amnesia in rodents,” Proceedings of the International Symposium on Brain Aging and Dementia: Basic and Translational Aspects, organized by Banaras Hindu University, Varanasi, India, 29-30 November, 2010.
[36] G. K. Singh and V. Kumar, “Beneficial effects of Fumaria indica in mental stress,” Proceedings of the 5th Congress of Federation of Asian and Oceanian Neuroscience Societies and XXVIII Annual Meeting of Indian Academy of Neurosciences, organized by Indian Institute of Toxicology Research, Lucknow, India, 25-28 November, 2010.
[37] G. K. Singh and V. Kumar, “Anxiolytic activity of standardized extract of Fumaria indica,” Proceedings of the 27th Annual Conference of Indian Academy of Neurosciences, organized by the NIMS University, Jaipur, India, 18-20 December, 2009. Abstract published in the Annals of Neurosciences, 2009, Vol. 16, No. l (Suppl.), p. 81.
[38] G. K. Singh, G. Rai, S. S. Chatterjee and V. Kumar, “Anti-aggressive, brain neurotransmitters and receptor binding study of Fumaria indica in rodents,” Current Psychpharmacology, 2012. In press.
[39] G. K. Singh, G. Rai, S. S. Chatterjee and V. Kumar, Potential antianxiety activity of Fumaria indica: A Preclinical Study. Pharmacognosy Magazine, 2012. In press.
[40] G. K. Singh, G. Rai, S. S. Chatterjee and V. Kumar, “Beneficial effects of Fumaria indica on chronic stress-induced neurobehavioral and biochemical perturbations in rats;” Chinese Medicine, Vol. 3, No.1, 2012, pp. 49-60.
[41] V. Kumar, G. K. Singh and G. Rai, “Biochemical study of Fumaria indica,” Proceedings of the12th International Congress of Ethnopharmacology- “Traditional Medicines and Globalization-The Future of Ancient Systems of Medicine”. Jadavpur University, Kolkata, India, 17-19 February, 2012.
[42] A. K. Thakur, S. S. Chatterjee and V. Kumar, “Potential of Andrographis panculata in brain disorders,” Proceedings of the International Conference on “Recent Advances in Pharmaceutical Science: Transferring Knowledge from Education to Practice” organised by Pharmanext in association with Kathmandu University, Pokhara University, Tribhuvan University and Purbanchal University, Nepal, 25-26 February, 2012.
[43] S. Pokharel, J. S. Tripathi, S. K. Tiwari, S. S. Chatterjee and V. Kumar, “Perspectives of Piper longum L. in neurological disorders,” Proceedings of the International Conference on “Recent Advances in Pharmaceutical Science: Transferring Knowledge from Education to Practice” organised by Pharmanext in association with Kathmandu University, Pokhara University, Tribhuvan University and Purbanchal University, Nepal, 25-26 February, 2012.
[44] S. Ineedi, A. Shakya, G. K. Singh and V. Kumar, “Role of hyperforin in diabetes and its associated hyperlipidemia in rats,” TANG: International Journal of Genuine Traditional Medicine, 2012. In press.
[45] J. Diamond “Medicine: diabetes in India,” Nature, Vol. 469, 2011, pp. 478-479.
[46] T. Rastogi, K. S. Reddy, M. Vaz, D. Spiegelman, D. Prabhakaran, W. C. Willett, M. J. Stampfer and A. Ascherio, “Diet and risk of heart disease in India,” The American Journal of Clinical Nutrition, Vol. 79, No. 4, 2004, pp. 582-592.
[47] A. K. Thakur and V. Kumar, “Beneficial effect of Brassica juncea in co-morbid depression associated with alloxan induced diabetes in rodents,” Proceedings of the International Conference on Recent Advances in Pharmaceutical Sciences, organized by the Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi, India, 22-23 December, 2010.
[48] A. K. Thakur and V. Kumar, “Beneficial effect of Brassica juncea in co-morbid anxiety associated with alloxan induced diabetes in rats,” Proceedings of the 43rd Annual Conference of Indian Pharmacological Society & International Conference on Pharmacology and Translational Research, organized by National Executive Committee 2010-IPS in Association with Food and Toxicology Research Centre, National Institute of Nutrition, Hyderabad, India, 13-16 December, 2010. Abstract published in the Indian Journal of Pha
[49] A. K. Thakur and V. Kumar, “Anti-amnesic activity of Brassica juncea in diabetic rats,” Proceedings of the 12th International Congress of Ethnopharmacology- “Traditional Medicines and Globalization-The Future of Ancient Systems of Medicine”. Jadavpur University, Kolkata, India, 17-19 February, 2012.
[50] E. Taylor, “The Mystery of Personality: A History of Psychodynamic Theories,” Springer Sciences, New York, USA, 2009.
[51] R. H. Singh, “Exploring large evidence-base for contemporary Ayurveda,” International Journal of Ayurveda Research, Vol. 1, No. 2, 2010, pp. 65-66.
[52] W. E. Stumpf, “Memo to the FDA and ICH: appeal for in vivo drug target identification and target pharmacokinetics Recommendations for improved procedures and requirements,” Drug Discovery Today, Vol. 12, No. 15-16, 2007, pp. 594-598.
[53] S. Kumanyika, R. W. Jeffery, A. Morabia, C. Rittenbaugh, V. J. Antipastis, and Public Health Approaches to the Prevention of Obesity (PHAPO) Working Group of the International Obesity Task Force (IOTF), “Obesity prevention: the case for action,” International Journal of Obesity, Vol. 26, No. 3, 2002, pp. 425-436.
[54] F. Gomez-Pinilla, “Brain food: the effects of nutrients on brain function,” Nature Reviews. Neuroscience, Vol. 9, No. 7, 2008, pp. 568-578.
[55] D. O. Kennedy and E. L. Wightman, “Herbal extracts and Phytochemicals: Plant secondary metabolites and the Enhancement of human brain functions,” Advances in Nutrition: An International Review, Vol. 2, 2011, pp. 32-50.
[56] A. P. Kulkarni, D. A. Govender, G. J. Kotwal and L. A. Kellway, “Modulation of anxiety behavior by intranasally administered vaccinia virus complement control protein and curcumin in a mouse model of Alzheimer`s disease,” Current Alzheimer Research, Vol. 8, No. 1, 2011, pp. 95-113.
[57] J. Chimakurthy and M. Talasila, “Effects of curcumin on pentylenetetrazole-induced anxiety-like behavior and associated changes in cognition and monoamine levels,” Psychology & Neuroscience, Vol. 3, No. 2, 2010, pp. 239-244.
[58] R. H. Singh, “Exploring issues in the development of Ayurvedic research methodology,” Journal of Ayurveda and Integrative Medicine, Vol. 1, No. 2, 2010, pp. 91-95.
[59] D. Wujastyk and F. M. Smith, “Modern and Global Ayurveda: Pluralism and Paradigms,” SUNY press, New York, USA, 2008.
[60] B. Patwardhan, “Traditional Medicine: Modern Approach for Affordable Global Health,” In: Commission on Intellectual Property Rights IaPHC, World Health Organisation (WHO), Geneva, 2005.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.